Biotech · Private company
Prilenia
Track this companyFree. Adds Prilenia to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- PridopidinePhase 3 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- PridopidinePhase 3 · Huntington DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PridopidinePhase 2 · Huntington's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PridopidinePhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Pridopidine Phase 3 Study in Huntington's DiseasePHASE3 · RECRUITING · started Jul 1, 2026ClinicalTrials.gov NCT07609108 · fetched Nov 12, 2026
- Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPHASE3 · RECRUITING · started Feb 1, 2026ClinicalTrials.gov NCT07322003 · fetched Nov 12, 2026
- HEALEY ALS Platform Trial - Regimen D PridopidinePHASE2_PHASE3 · COMPLETED · started Dec 18, 2020ClinicalTrials.gov NCT04615923 · fetched Nov 12, 2026
- PRidopidine's Outcome On Function in Huntington Disease, PROOF- HDPHASE3 · COMPLETED · started Oct 16, 2020ClinicalTrials.gov NCT04556656 · fetched Nov 12, 2026
- A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's DiseasePHASE2 · TERMINATED · started May 22, 2019ClinicalTrials.gov NCT03922711 · fetched Nov 12, 2026
- A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's DiseasePHASE2 · TERMINATED · started Sep 24, 2015ClinicalTrials.gov NCT02494778 · fetched Nov 12, 2026
- A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's DiseasePHASE2 · COMPLETED · started Feb 28, 2014ClinicalTrials.gov NCT02006472 · fetched Nov 12, 2026
- A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)NO_LONGER_AVAILABLEClinicalTrials.gov NCT06069934 · fetched Nov 12, 2026